FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 41 filers reported holding FINCH THERAPEUTICS GROUP INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $93,359 | -18.1% | 237,553 | 0.0% | 0.02% | -25.0% |
| Q4 2022 | $114,026 | -71.3% | 237,553 | 0.0% | 0.03% | -64.6% |
| Q3 2022 | $397,000 | -57.7% | 237,553 | -28.1% | 0.08% | -53.8% |
| Q2 2022 | $938,000 | -43.6% | 330,523 | 0.0% | 0.17% | -21.9% |
| Q1 2022 | $1,662,000 | -47.2% | 330,523 | +4.7% | 0.22% | -53.3% |
| Q4 2021 | $3,148,000 | -23.3% | 315,732 | 0.0% | 0.47% | +62.3% |
| Q3 2021 | $4,106,000 | -10.2% | 315,732 | -2.9% | 0.29% | -21.9% |
| Q2 2021 | $4,573,000 | +91.6% | 325,000 | +116.7% | 0.37% | +362.5% |
| Q1 2021 | $2,387,000 | – | 150,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |